Department of Orthopedics, Orthopedic Research Institute, West China Hospital, West China Medical School, Sichuan University, #37 Guoxue Road, Chengdu, 610041, Sichuan Province, People's Republic of China.
J Orthop Surg Res. 2022 Feb 11;17(1):85. doi: 10.1186/s13018-022-02955-3.
Given the possibility of inadvertent bacterial contamination of salvaged blood, the use of cell salvage is relatively contraindicated in cases of reimplantation for chronic hip periprosthetic joint infection (PJI). However, there are no published data supporting this assertion. The purpose of the current study was to compare the reinfection rate and rate of postoperative allogeneic blood transfusion (ABT) in second-stage reimplantation for PJI with or without intraoperative cell salvage reinfusion.
We identified 125 patients who underwent two-stage exchange for chronic hip PJI between November 2012 and April 2019. The groups of patients who had (n = 61) and had not (n = 64) received intraoperative cell salvage reinfusion were compared with respect to the curative infection-free rate. Moreover, we compared the need for postoperative ABT and identified independent factors associated with ABT using multiple regression analysis.
The log-rank survival curve with an endpoint of infection eradication failure was not significantly different between the cell salvage group (98.4%, 95% CI 95.3-99.9%) and the control group (95.3%, 95% CI 90.2-99.9%) at one year (log rank, P = .330). The rates of postoperative ABT in the cell salvage group were significantly lower than those in the control group (11.5% vs 26.6%, P = .041). In multivariable models, patient age, body mass index, preoperative hemoglobin level, and intraoperative cell salvage were independent predictors of ABT exposure (P < .05).
The use of cell salvage during reimplantation in two-stage exchange for chronic hip PJI did not appear to increase the reinfection rate, while it significantly reduced the rate of postoperative allogeneic red blood transfusion. Greater age, lower BMI, lower preoperative hemoglobin, and non-intraoperative cell salvage reinfusion were associated with higher rate of allogeneic red blood transfusion.
由于回收血液中可能存在细菌污染,因此在慢性髋关节假体周围关节感染(PJI)再植入的情况下,相对禁忌使用细胞回收。然而,目前还没有数据支持这一观点。本研究的目的是比较术中细胞回收再输注与不输注在慢性髋关节 PJI 二期翻修中的再感染率和术后异体输血(ABT)率。
我们共纳入 125 例 2012 年 11 月至 2019 年 4 月间因慢性髋关节 PJI 行二期翻修的患者。比较了术中接受细胞回收再输注(n=61)和未接受细胞回收再输注(n=64)的两组患者的治愈率。此外,我们还比较了术后 ABT 的需求,并通过多元回归分析确定了 ABT 的独立相关因素。
以感染清除失败为终点的对数秩生存曲线在细胞回收组(98.4%,95%CI 95.3-99.9%)和对照组(95.3%,95%CI 90.2-99.9%)之间没有显著差异(对数秩检验,P=0.330)。细胞回收组术后 ABT 率显著低于对照组(11.5% vs 26.6%,P=0.041)。在多变量模型中,患者年龄、体重指数、术前血红蛋白水平和术中细胞回收是 ABT 暴露的独立预测因素(P<0.05)。
在慢性髋关节 PJI 二期翻修中,细胞回收的使用似乎不会增加再感染率,同时显著降低了术后异体红细胞输血率。年龄较大、BMI 较低、术前血红蛋白较低和术中未进行细胞回收再输注与更高的异体红细胞输血率相关。